MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Reduces Stock Holdings in Omega Healthcare Investors, Inc. $OHI

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. trimmed its stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 43.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 536,208 shares of the real estate investment trust's stock after selling 409,669 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned approximately 0.19% of Omega Healthcare Investors worth $20,419,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. NBC Securities Inc. bought a new position in shares of Omega Healthcare Investors in the first quarter worth approximately $29,000. CoreCap Advisors LLC increased its position in shares of Omega Healthcare Investors by 177.3% in the fourth quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust's stock worth $60,000 after purchasing an additional 1,009 shares during the last quarter. Park Square Financial Group LLC bought a new position in shares of Omega Healthcare Investors in the fourth quarter worth approximately $61,000. UMB Bank n.a. increased its position in shares of Omega Healthcare Investors by 94.9% in the first quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock worth $83,000 after purchasing an additional 1,059 shares during the last quarter. Finally, Meeder Asset Management Inc. boosted its stake in Omega Healthcare Investors by 1,581.3% in the first quarter. Meeder Asset Management Inc. now owns 2,522 shares of the real estate investment trust's stock worth $96,000 after buying an additional 2,372 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director directly owned 18,654 shares in the company, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.50% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on OHI. Scotiabank increased their price target on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a research report on Thursday, August 28th. Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Truist Financial increased their price target on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research report on Wednesday, September 3rd. Mizuho increased their price target on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a research report on Thursday. Finally, Royal Bank Of Canada increased their price objective on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research note on Thursday, August 7th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. Based on data from MarketBeat, Omega Healthcare Investors currently has an average rating of "Moderate Buy" and a consensus target price of $43.75.

Omega Healthcare Investors Stock Down 0.0%

Omega Healthcare Investors stock traded down $0.01 on Friday, hitting $42.49. 1,550,013 shares of the stock traded hands, compared to its average volume of 1,686,146. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The firm has a market cap of $12.53 billion, a P/E ratio of 26.23, a price-to-earnings-growth ratio of 2.23 and a beta of 0.71. The business's fifty day simple moving average is $40.26 and its 200 day simple moving average is $38.24. Omega Healthcare Investors, Inc. has a 1 year low of $35.04 and a 1 year high of $44.42.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business had revenue of $235.60 million during the quarter, compared to analyst estimates of $248.49 million. During the same quarter last year, the firm posted $0.71 earnings per share. The company's revenue for the quarter was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, sell-side analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.3%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio (DPR) is presently 165.43%.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.